Literature DB >> 2358856

Rapid estimation of the proliferating index of brain tumours.

A Detta1, E Hitchcock.   

Abstract

A rapid and versatile method has been developed for estimating proliferating/labelling indices (enumerated S-phase cells) of brain tumours. Fragments of fresh, surgically excised tumour specimens are labelled in vitro with 10 microM bromodeoxyuridine (BrdU) at 37 degrees for 1 hour in MEM + 10% FCS, washed in PBS, blotted dry and then imprinted on glass slides leaving a mirror image monolayer of cells of the impressed surface. The incorporated BrdU is then detected indirectly by immunoperoxidase staining after fixation. No fewer than 1000 cells are counted under high power and the PI is expressed as the % of BrdU positive cells to the total number counted. The PI of the various tumours analysed ranged 2.54-13.08% for gliomas, 5.29-7.60% for metastases, 0-0.83% for benign meningiomas. Thirty one cases have been studied. Results, obtainable within a few hours of tumour biopsy/resection, correlate favourably with published flow-cytometry proliferating indices for the tumours analysed and thus validate the method as a comparable alternative to in vivo BrdU labelling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358856     DOI: 10.1007/bf00177357

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Comparison of smear and imprint techniques for rapid diagnosis in neuro-oncology.

Authors:  E Hitchcock; C S Morris; M G Sotelo; M Salmon
Journal:  Surg Neurol       Date:  1986-08

2.  Cell kinetics of human gliomas.

Authors:  T Hoshino; M Barker; C B Wilson; E B Boldrey; D Fewer
Journal:  J Neurosurg       Date:  1972-07       Impact factor: 5.115

3.  Cell microfluorometry: a method for rapid fluorescence measurement.

Authors:  M A Van Dilla; T T Trujillo; P F Mullaney; J R Coulter
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  A cell kinetic study on medulloblastomas.

Authors:  T Hoshino; S Kobayashi; J J Townsend; C B Wilson
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

6.  Growth rate of human pituitary adenomas.

Authors:  A M Landolt; T Shibata; P Kleihues
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

7.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

8.  Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.

Authors:  T Nagashima; T Hoshino; K G Cho; M Senegor; F Waldman; K Nomura
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

9.  Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.

Authors:  K G Cho; T Hoshino; T Nagashima; J A Murovic; C B Wilson
Journal:  J Neurosurg       Date:  1986-12       Impact factor: 5.115

10.  In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.

Authors:  T Hoshino; T Nagashima; J A Murovic; C B Wilson; M S Edwards; P H Gutin; R L Davis; S J DeArmond
Journal:  J Neurosurg       Date:  1986-03       Impact factor: 5.115

View more
  3 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 2.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.

Authors:  K Kharbanda; A K Dinda; C Sarkar; A K Karak; R Dhir; M Mathur; S Roy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.